Skip to main content

Find Clinical Trials

Home
Conditions
Meningitis

Clinical trial condition

Meningitis

Explore clinical trials studying Meningitis. Study availability and eligibility vary by location and protocol.

216 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Meningitis trial results

Completed

Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis

NCT01802385

Conditions: Bacterial Infections and Mycoses, Central Nervous System Diseases, Central Nervous System Fungal Infections, +11 more
Locations: Infectious Disease Institute Kampala, Uganda

Mbarara University of Science and Technology Mbarara, Uganda

View Trial Details

Completed

Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)

NCT03630250

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +8 more
Locations: NIHR Southampton Clinical Research Facility Southampton, United Kingdom

View Trial Details

Completed

Neurologic Manifestations of the Arbovirus Infection in Colombia

NCT03206541

Conditions: Alphavirus Infections, Arbovirus Infections, Autoimmune Diseases, +40 more
Locations: Clinica Leon XIII Medellín, Antioquia, Colombia

Neuroclinica Medellín, Antioquia, Colombia

Clinica La Misericordia Internacional Barranquilla, Atlántico, Colombia

Hospital Universitario de Narino Pasto, Departamento de Nariño, Colombia

View Trial Details

Completed

Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years

NCT03587207

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: GSK Investigational Site Hradec Králové, Czechia

View Trial Details

Completed

Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.

NCT03378258

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +18 more
Locations: Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom

View Trial Details

Completed

Reduced PCV Dosing Schedules in South African Infants

NCT02943902

Conditions: Infections, Lung Diseases, Meningitis, +5 more
Locations: Chris Hani Baragwanath Academic Hospital Johannesburg, Gauteng, South Africa

Nrf/Dst Vpd Rmpru Soweto, GP, South Africa

View Trial Details

Completed

Treatment With Tamoxifen in Cryptococcal Meningitis

NCT03112031

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, Blood-Borne Infections, +30 more
Locations: Cho Ray Hospital Ho Chi Minh City, Vietnam

Hospital for Tropical Diseases Ho Chi Minh City, Vietnam

Oxford University Clinical Research Unit Ho Chi Minh City, Vietnam

View Trial Details

Completed

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

NCT02986854

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Anaheim, California, United States

View all 37 locations

View Trial Details

Completed

The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)

NCT03710278

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +31 more
Locations: Spartanburg Reginal Heathcare System Spartanburg, South Carolina, United States

View Trial Details

Completed

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

NCT02946385

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: GSK Investigational Site Espoo, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Jarvenpaa, Finland

View all 17 locations

View Trial Details